LOGIN
Autologous Dermal Fibroblast Injection Reduces Retear Rate After Rotator Cuff Repair
June 2025
Autologous Dermal Fibroblast Injection Reduces Retear Rate After Rotator Cuff Repair
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Efficacy of an Autologous Dermal Fibroblast Injection in Reducing the Retear Rate After Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial.
Am J Sports Med . 2025 Mar;53(3):592-599.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Seventy-three patients with full-thickness rotator cuff tears >2 cm were randomized to receive either an autologous dermal fibroblasts (ADF) injection during arthroscopic rotator cuff repair (n=36) or arthroscopic rotator cuff repair (ARCR) alone (n=37). The primary outcome was the retear rate at 6 months, assessed by MRI. Secondary outcomes included American Shoulder and Elbow Surgeons (ASES) sco...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.